Jan 10, 2023 / NTS GMT
Richard Vosser - JPMorgan Chase & Co, Research Division - Senior Analyst
Welcome to the Sanofi presentation at the 41st JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan, and it's my great pleasure to introduce Paul Hudson, the CEO of Sanofi.
Before I hand over to Paul, just to remind everyone, we will take Q&A after Paul's presentation in this room. Please put your hand up and wait for a microphone, and then we'll take your question. Paul, welcome to the conference.
Paul Hudson - Sanofi - CEO & Director
Okay. Thank you, Richard. Thank you. Can you hear me okay? What a wonderful and warm introduction, Richard, thank you very much for that. It's 3 years since that we've been here together at least, and it used to be the big room, I think, and then a scramble to get to the small room for the Q&A. I think I prefer this already. So let's see how far we get.
In those 3 years, an awful lot has happened for us at Sanofi. We've really been on our journey, really transforming the company, really
Sanofi SA at JPMorgan Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers